| Charlene K Porter, AA-C | |
|
9500 Euclid Ave, Cleveland, OH 44195-0001 | |
| (216) 444-4633 | |
| Not Available |
| Full Name | Charlene K Porter |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 25 Years |
| Location | 9500 Euclid Ave, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962467589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 67.000039 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
After showing that a 10-week therapeutic horseback riding intervention reduced irritability and hyperactivity while improving the social communication skills of youth diagnosed with autism spectrum disorder, University of Colorado Anschutz Medical Campus researcher and Children's Hospital Colorado psychologist, Dr. Robin Gabriels, has received a $2.5 million grant to investigate why the therapy works.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2009.
Acceptance and commitment therapy shows promise for treating fear of cancer recurrence in women who have survived breast cancer.
The White House, however, opposes the bill on grounds that it could weaken the health law's consumer protections, although it stopped short of threatening a veto.
UCLA researchers have identified a new biomarker that could help them track how effectively the immune system is able to clear the brain of amyloid beta, which forms the plaques considered one of the hallmarks of Alzheimer's disease.
› Verified 1 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
After showing that a 10-week therapeutic horseback riding intervention reduced irritability and hyperactivity while improving the social communication skills of youth diagnosed with autism spectrum disorder, University of Colorado Anschutz Medical Campus researcher and Children's Hospital Colorado psychologist, Dr. Robin Gabriels, has received a $2.5 million grant to investigate why the therapy works.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2009.
Acceptance and commitment therapy shows promise for treating fear of cancer recurrence in women who have survived breast cancer.
The White House, however, opposes the bill on grounds that it could weaken the health law's consumer protections, although it stopped short of threatening a veto.
UCLA researchers have identified a new biomarker that could help them track how effectively the immune system is able to clear the brain of amyloid beta, which forms the plaques considered one of the hallmarks of Alzheimer's disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charlene K Porter, AA-C 19418 Saratoga Trl, Strongsville, OH 44136-7273 Ph: (440) 238-0593 | Charlene K Porter, AA-C 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (216) 444-4633 |
News Archive
After showing that a 10-week therapeutic horseback riding intervention reduced irritability and hyperactivity while improving the social communication skills of youth diagnosed with autism spectrum disorder, University of Colorado Anschutz Medical Campus researcher and Children's Hospital Colorado psychologist, Dr. Robin Gabriels, has received a $2.5 million grant to investigate why the therapy works.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2009.
Acceptance and commitment therapy shows promise for treating fear of cancer recurrence in women who have survived breast cancer.
The White House, however, opposes the bill on grounds that it could weaken the health law's consumer protections, although it stopped short of threatening a veto.
UCLA researchers have identified a new biomarker that could help them track how effectively the immune system is able to clear the brain of amyloid beta, which forms the plaques considered one of the hallmarks of Alzheimer's disease.
› Verified 1 days ago
Shannon Kelly, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Olivia Kehoe, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-1000 | |
Brian Michael Wheatley, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Nicole M Moses, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Michael Marcotte, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Thomas Bruno, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7330 | |
Gregory G Kychun, AA Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-7330 |